What's more, although we detected differences in plasma Wnt2b level between the AD and cognitively normal groups, we will expand the sample size and enroll mild cognitive impairment subjects to further validate the relationship between plasma Wnt2b and cognitive function in AD. This evidence concerns the gene WNT2B and Cognitive impairment.